Antiretroviral Therapy for Acute and Chronic HIV Infection

Trial Profile

Antiretroviral Therapy for Acute and Chronic HIV Infection

Recruiting
Phase of Trial: Phase III

Latest Information Update: 05 Jul 2018

At a glance

  • Drugs Efavirenz (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Maraviroc; Raltegravir
  • Indications HIV-1 infections
  • Focus Therapeutic Use
  • Acronyms AAHIV
  • Most Recent Events

    • 05 Jul 2018 Planned number of patients changed from 536 to 549.
    • 26 Jun 2018 Parallel assignment has been changed to single group assignment, randomized has been remove. Number of treatment arms has been changed from 2 to 1. Planned patients has also increased.
    • 17 Apr 2018 Planned number of patients changed from 500 to 536.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top